Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (387)

  • Echarri-Martinez, L; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Garcia-Lopez, I; Lopez-Herce, J; Sanjurjo-Saez, M.

    Pharmaceutical care in paediatric intensive care unit: activities and interdisciplinary learning in a Spanish hospital

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2012; 19(4): 416-422 Nº de citas: 5 [doi:10.1136/ejhpharm-2011-000032]

  • Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Perez-Sanz, C; Duran-Garcia, ME; Sanjurjo-Saez, M; Calleja-Hernandez, MA.

    Validation of a method for recording pharmaceutical interventions

    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2012; 37(4): 459-463 Nº de citas: 14 [doi:10.1111/j.1365-2710.2011.01328.x]

  • Cortejoso, L; Lopez-Fernandez, LA.

    Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

    PHARMACOGENOMICS. 2012; 13(10): 1173-1191 Nº de citas: 21 [doi:10.2217/PGS.12.95]

  • Ines, YG; Monica, FM; Esther, DG; Belen, MA; Alvaro, GM; Maria, SS.

    FERRIC CARBOXYMALTOSE: EFFICACY AND SAFETY

    Atencion Farmaceutica. 2012; 14(4): 251-261 Nº de citas: 1

  • Fernandez-Llamazares, CM; Calleja-Hernandez, MA; Manrique-Rodriguez, S; Perez-Sanz, C; Duran-Garcia, E; Sanjurjo-Saez, M.

    Impact of clinical pharmacist interventions in reducing paediatric prescribing errors

    ARCHIVES OF DISEASE IN CHILDHOOD. 2012; 97(6): 564-568 Nº de citas: 31 [doi:10.1136/archdischild-2011-301239]

  • Gras, R; Relloso, M; Garcia, MI; de la Mata, FJ; Gomez, R; Lopez-Fernandez, LA; Munoz-Fernandez, MA.

    The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16

    BIOMATERIALS. 2012; 33(15): 4002-4009 Nº de citas: 15 [doi:10.1016/j.biomaterials.2012.02.018]

  • Manrique-Rodriguez, S; Sanchez-Galindo, A; Fernandez-Llamazares, CM; Lopez-Herce, J; Echarri-Martinez, L; Escudero-Vilaplana, V; Sanjuro-Saez, M; Carrillo-Alvarez, A.

    Smart pump alerts: All that glitters is not gold

    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2012; 81(5): 344-350 Nº de citas: 20 [doi:10.1016/j.ijmedinf.2011.10.010]

  • Vicenta, EV; Antonio, MM; Esther, DG; Maria, GA; Teresa, BM; Maria, SS.

    IMPACT OF THE IMPLEMENTATION OF A THERAPEUTIC EQUIVALENCE PROGRAM

    Atencion Farmaceutica. 2012; 14(3): 210-212

  • Manrique-Rodríguez S; Sánchez-Galindo A; Mora-García T; Fernandez-Llamazares CM; Echarri-Martínez L; López-Herce J; Rodríguez-Gómez M; Bellón-Cano JM; Sanjuro-Sáez M.

    Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit.

    Journal Of Infusion Nursing : The Official Publication Of The Infusion Nurses Society. 2012; 35(2): 109-114 Nº de citas: 13 [doi:10.1097/NAN.0b013e3182425b34]

  • Escudero-Vilaplana, V; Aragones, JH; Fernandez-Llamazares, CM; Bieler, CB; Rodriguez, SM; Saez, S.

    Use of Romiplostim for Primary Immune Thrombocytopenia in Children

    PEDIATR HEMAT ONCOL. 2012; 29(2): 197-205 Nº de citas: 20 [doi:10.3109/08880018.2011.629401]

  • Manrique-Rodriguez, S; Sanchez-Galindo, A; Fernandez-Llamazares, CM; Lopez-Herce, J; Garcia-Lopez, I; Carrillo-Alvarez, A; Sanjuro-Saez, M.

    Developing a drug library for smart pumps in a pediatric intensive care unit

    ARTIF INTELL MED. 2012; 54(3): 155-161 Nº de citas: 22 [doi:10.1016/j.artmed.2011.12.001]

  • Gras, R; Garcia, MI; Gomez, R; de la Mata, FJ; Munoz-Fernandez, MA; Lopez-Fernandez, LA.

    Carbosilane Dendrimer 2G-NN16 Represses Tc17 Differentiation in Primary T CD8+ Lymphocytes

    MOLECULAR PHARMACEUTICS. 2012; 9(1): 102-110 Nº de citas: 9 [doi:10.1021/mp200305u]

  • Rodriguez-Gonzalez, CG; Herranz-Alonso, A; Martin-Barbero, ML; Duran-Garcia, E; Durango-Limarquez, MI; Hernandez-Sampelayo, P; Sanjurjo-Saez, M.

    Prevalence of medication administration errors in two medical units with automated prescription and dispensing

    J AM MED INFORM ASSN. 2012; 19(1): 72-78 Nº de citas: 56 [doi:10.1136/amiajnl-2011-000332]

  • Lopez-Casas, PP; Mizrak, SC; Lopez-Fernandez, LA; Paz, M; de Rooij, DG; del Mazo, J.

    The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

    REPROD TOXICOL. 2012; 33(1): 106-115 Nº de citas: 35 [doi:10.1016/j.reprotox.2011.12.012]

  • Lucia, CF; Rosa, RJM; Sagrario, PLM; Maria, MA; Maria, SS.

    Effectiveness and Safety of Abatacept in Moderate to Severe Rheumatoid Arthritis

    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2012; 15(1): 46-51 Nº de citas: 1

  • Escudero-Vilaplana, V; Ramirez-Herraiz, E; Trovato-Lopez, N; Alanon-Plaza, E; Bellini, MJ; Herranz-Alonso, A; Bellon-Cano, JM; Morell-Baladron, A; Sanjurjo-Saez, M.

    Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis

    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2012; 15(3): 355-360 Nº de citas: 8 [doi:10.18433/J33W30]

  • Lucia, C; Silvia, MR; Cecilia, MFL; Sanjurjo-Saez, M.

    Treatment and Prophylaxis of Catheter-Related Thromboembolic Events in Children

    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2012; 15(5): 632-641 Nº de citas: 10 [doi:10.18433/J34P4M]

  • Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Sanjurjo-Saez, M.

    Drug use safety in paediatrics

    Archivos Argentinos de Pediatria. 2011; 109(6): 510-518 Nº de citas: 7 [doi:10.5546/aap.2011.510]